Besides their unique developmental properties, V␣14 NKT cells are shown to recognize glycolipid antigens in the context with a monomorphic CD1d (6, 7), whose mode of antigen recognition is entirely distinct from that of conventional T cells that recognize peptide antigens in association with the MHC, which is polymorphic in nature. Therefore, NKT cells seem to constitute a novel immune system mainly against glycolipid antigens. Moreover, V␣24J␣Q T cells, a human counterpart for V␣14 NKT cells, have been identified (1) and are shown to recognize CD1d molecules (8, 9) . The conservation of the invariant V␣14 NKT cell receptor and of the recognition of CD1d ligand through evolution implies a critical role of V␣14 NKT cells in a host-defense system.
V␣14 natural killer T (NKT) cells constitute a unique lineage of lymphocytes distinct from conventional ␣␤ T cells, natural killer (NK) cells, and B cells and are characterized by the coexpression of NK cell marker NK1.1 and the invariant antigen receptor encoded by V␣14 and J␣281 gene segments preferentially associated with the V␤8.2 chains (1, 2). Two lines of evidence clearly demonstrate V␣14 NKT cells as a novel lineage of lymphocytes: (i) V␣14 NKT cells develop at the embryo body but not yolk sac as early as day 9.5 of gestation, before thymus formation (3) , and (ii) a targeted disruption of the invariant V␣14 NKT receptor gene causes a selective loss of the V␣14 NKT cells, leaving other lymphocytes intact (4) , whereas a transgenic expression of the invariant V␣14 NKT receptor and͞or V␤8.2 genes with T cell antigen receptor ␣ (TCR␣)-deficient and recombination activating gene (RAG)-deficient background results in an exclusive development of V␣14 NKT cells (5, 6) . These studies suggest an essential role for the invariant V␣14 NKT receptor in the development and lineage commitment of V␣14 NKT cells but not other populations.
Besides their unique developmental properties, V␣14 NKT cells are shown to recognize glycolipid antigens in the context with a monomorphic CD1d (6, 7) , whose mode of antigen recognition is entirely distinct from that of conventional T cells that recognize peptide antigens in association with the MHC, which is polymorphic in nature. Therefore, NKT cells seem to constitute a novel immune system mainly against glycolipid antigens. Moreover, V␣24J␣Q T cells, a human counterpart for V␣14 NKT cells, have been identified (1) and are shown to recognize CD1d molecules (8, 9) . The conservation of the invariant V␣14 NKT cell receptor and of the recognition of CD1d ligand through evolution implies a critical role of V␣14 NKT cells in a host-defense system.
A great deal of effort has been made to identify the molecules essential for the development of V␣14 NKT cells. In particular, studies with various genetically manipulated mice have revealed that NKT cell development depends on the molecules, including ␤ 2 -microglobulin (␤ 2 m) (10-12), CD1d (13) (14) (15) , pT␣ (16) , RAG-1 and 2 (17) , TCF-1 (18) , and J␣281 (4) . These results suggest that V␣14 NKT cells are differentiated through selection events mediated by various cell surface receptors, such as mature or immature forms of NKT cell antigen receptors and cytokine receptors during the interaction with CD1d-expressing stroma cells. However, neither precursor populations nor precise molecular requirement for the development of V␣14 NKT cells has been clarified.
Such emerging views on a novel subset of lymphocytes prompted us to search for their precursors and molecular requirements for NKT cell differentiation. Here, we have identified a precursor of mature V␣14 NKT cells and characterized the molecular requirements for differentiation. In addition, granulocyte͞macrophage colony-stimulating factor (GM-CSF) is found to be a critical molecule for the initiation of the V␣14 NKT receptor gene rearrangement during the development of these lymphocytes.
MATERIALS AND METHODS
Mice. C57BL͞6 mice were obtained from Japan SLC (Hamamatsu, Japan mice to RAG-1 Ϫ/Ϫ mice. Common ␤ (␤c)-deficient mice, which were generated originally by Nishinakamura et al. (19) , were kindly provided by H. Nakauchi (Tsukuba University). RAG-1 Ϫ/Ϫ mice were used as a source of feeders. All animals were maintained under specific pathogen-free conditions.
Antibodies. mAbs against Fc␥ receptors II and III (Fc␥RII͞ III) (2.4G2), TCR␣␤ (H57-597), NK1.1 (PK136), CD3 (145-2C11), V␤8 (F23.1), Gr1 (RB6-8C5), TER119 (TER-119), CD19 (1D3), anti-Thy-1 (53-2.1), and anti-B220 (RA3-6B2) were obtained from PharMingen except for anti-V␣14 mAb (5). Cychrome-streptavidin (PharMingen) was used for the detection of biotinylated antibodies.
Flow Cytometric Analysis. Freshly prepared or cultured cells (1 ϫ 10 6 ) were stained as described (5) . The specificity of staining was confirmed by using isotype-matched
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Abbreviations: NK, natural killer; GM-CSF, granulocyte͞macrophage colony-stimulating factor; RT-PCR, reverse transcription-PCR; PIPLC, phosphatidylinositol-specific phospholipase C; sCD3, surface CD3; TCR, T cell receptor; tg, transgenic; BM, bone marrow; ␤c, common ␤; ␤2m, ␤2-microglobulin. § To whom reprint requests should be addressed. e-mail: taniguti@ med.m.chiba-u.ac.jp. irrelevant mAbs or preincubating cells with an excess amount of the unlabeled mAb before staining with the fluorochromeconjugated staining mAb (cold blocking). Stained cells were analyzed on an Epics XL flow cytometer (Coulter). Data were live-gated by size and lack of propidium iodide uptake. In Fig.  1C , 1 ϫ 10 6 cells were incubated with 0.3 unit of phosphatidylinositol-specific phospholipase C (PIPLC; Boehringer Mannheim) in 1% BSA-supplemented RPMI 1640 medium at 37°C, in 5% CO 2 for 1 hr, washed, stained, and then analyzed in a way similar to that described above.
Cell RT-PCR. PCR amplifications except for pT␣, GM-CSFR␣, and ␤c were performed under the conditions as described (3, 5) . PCR primers for pT␣, GM-CSFR␣, and ␤c were 5Ј-CTG-GTGGTTTGCCTGGTCCTC-3Ј and 5Ј-GTGGGTGGGAG-GCAGGGACTT-3Ј for pT␣, 5Ј-CTCGACCTGGGCATCC-TT-3Ј and 5Ј-CACGTCGTCGGACACCTTGT-3Ј for GM-CSFR␣, and 5Ј-ATGCTCTCCGGTGGTGAA-3Ј and 5Ј-TG-GCGCAGTATGAGGTGTCT-3Ј for ␤c. DNA was amplified for 35 cycles at annealing temperatures at 60°C for pT␣, 68°C for GM-CSFR␣, and 65°C for ␤c. The radioactivities of DNA blots of PCR products were measured by a BioImage Analyzer (Fuji) (3, 5) . The probes for the detection were 5Ј-GCAGA-AGCAGTTTGAAGAGGA-3Ј for pT␣, 5Ј-GCGGGCGAC-ACGAGGATGAAG-3Ј for GM-CSFR␣, and 5Ј-CCGGGG-GCCAGTGTCTACACC-3Ј for ␤c.
Genomic PCR. Detection of coding and signal sequences of V␣14 as well as RAG-2 genes was performed as described (20) . Nuclear DNA was amplified by nested PCR for circular DNA detection. PCR was carried out for 30 cycles and then followed by 35 cycles of amplification by using the second set of primers. The primer sequences and the detection probes have been published (20) .
Competitive PCR. The competitor DNAs were constructed by PCR by using a competitor DNA construction kit following the manufacturer's instructions (Takara Shuzo, Kyoto). After the amounts of input DNA were equalized (600 ng per lane for freshly isolated cells, comparable to about 10 5 cells, 300 ng per lane for cultured cells for circular V␣14-J␣281, and 300 ng per lane for genomic V␣14-J␣281 detection), the mixture of the DNA and defined copy numbers of competitors was subjected to nested PCR amplifications under the same conditions as above. The ratio of a longer competitive product to a shorter target DNA product was used to estimate the amounts of target DNAs (363 bp vs. 310 bp for genomic V␣14-J␣281, and 348 bp vs. 288 bp for circular V␣14-J␣281).
RESULTS

Phenotypic Characterization of TCR␤
؉ NKT Cells in the TCR V␤8.2 tg Spleen Cells. The goal of this study is to determine the molecular requirement for the differentiation of a novel subset of lymphocytes, V␣14 NKT cells. C57BL͞6 splenocytes contained 1-2% of mature NKT cells that coexpressed NK1.1 and intermediate levels of TCR␤ and CD3 on the cell surface (Fig. 1A, first row) . However, in the spleen cells of mice with transgenic V␤8.2, which is used preferentially by V␣14 NKT cells, all of NK1.1 ϩ cells expressed TCR␤, and about 80% of them were negative for surface CD3 (sCD3) expression ( Fig. 1 A, (Fig. 1 A, third row) , indicating the essential requirement of ␣-chain gene rearrangements for the generation of sCD3 ϩ NKT cells. In fact, the introduction of the rearranged invariant V␣14 gene into RAG-1 Ϫ/Ϫ V␤8.2 tg mice resulted in increased numbers of sCD3 ϩ NKT cells (1.6-40%) and also in the significant expression of V␣14 on NKT cells ( Fig. 1 A, Fig. 1 A) . It might be a result of the V␤8.2 tg situation, in which precursor cell differentiation is accelerated by the forced expression of the rearranged NKT antigen receptor, V␤8.2 ␤-chain. The precise mechanism for surface expression of the TCR␤ chains without CD3 complex remains unclear. At least the TCR␤ chains on sCD3 Ϫ NKT cells seemed not to be anchored via glycosyl-phosphatidylinositol (GPI), because they were highly resistant to the digestion with PIPLC (Fig. 1C) . Phenotypic characterization of sCD3 Ϫ NKT cells revealed that they express CD44, Thy-1 (40.0%), and IL-2 receptor ␤ (IL-2R␤) on their surface, but not CD3, CD4, CD8, c-kit, or CD25 (data not shown). This phenotype is reminiscent of immature c-kit Ϫ , CD44 To elucidate further molecular properties of sCD3 Ϫ NKT cells, both sCD3 Ϫ and sCD3 ϩ NKT cells were purified from BM cells of V␤8.2 tg mice and were subjected to RT-PCR analysis (Fig. 1B) . The rearranged V␣14 TCR transcripts were detected in sCD3 ϩ NKT cells, but not in sCD3 Ϫ NKT cells (Fig. 1B, top blot) . Despite their undetectable sCD3 expression, considerable amounts of CD3 transcripts were detected in the sCD3 Ϫ NKT cells. As expected, sCD3 Fig. 2A ) and subjected to a short-term culture with BM feeder cells from RAG-1
mice in the presence of IL-15 and GM-CSF. As shown in Fig. 2B , neither IL-15 alone nor the combined use of IL-2 and GM-CSF supported the development of mature sCD3 ϩ V␣14 NKT cells, whereas significant numbers of sCD3 ϩ V␣14 NKT cells were generated in the presence of both IL-15 and GM-CSF. Importantly, expression of ␤ 2 m or its associated class I-like molecules on BM stroma cells was found to be required because the development of mature V␣14 NKT cells was hampered severely when ␤ 2 m Ϫ/Ϫ BM cells were used (Fig. 2B,  bottom row) .
The differentiation of V␣14 NKT cells was confirmed further at a molecular level. The starting population of sCD3 Ϫ pre-NKT cells showed no significant V␣14-J␣281 gene rearrangement at the level of circular DNA and genomic DNA (Fig. 2C, first lane) . After 5-day culture with IL-15 and GM-CSF, significant amounts of both circular DNA generated by V␣14-J␣281 gene rearrangement (circular V␣14-J␣281) and rearranged genomic DNA became detectable, suggesting ongoing V␣14-J␣281 gene rearrangement (Fig. 2C , second lane). These results excluded a possibility that mature V␣14 NKT cells detected were consequences of a simple expansion of a minor contaminant of mature NKT cells in the sorted cell samples.
Further RT-PCR analysis revealed that the rearranged invariant V␣14 gene indeed was transcribed (Fig. 2D) , indicating that mature V␣14 NKT cells were generated from pre-NKT cells in situ. In addition, the RAG-1 gene expression was down-regulated and disappeared after the culture. Based on both phenotypic and molecular evidence, we concluded that sCD3 Ϫ pre-NKT cells contained precursor cells that differentiated in vitro into mature V␣14 NKT cells with BM stroma cells in the presence of both IL-15 and GM-CSF.
Induction of V␣14 Gene Rearrangement in sCD3
؊ pre-NKT Cells by GM-CSF. Our present study clearly showed that IL-15 and GM-CSF induced differentiation of sCD3 Ϫ pre-NKT cells to mature sCD3 ϩ V␣14 NKT cells (Fig. 2) . To examine the possibility that either IL-15 or GM-CSF directly induced V␣14 gene rearrangement in pre-NKT cells, the purified sCD3 Ϫ pre-NKT cells were cultured without feeder cells for a very short period (12, 24 , and 36 hr) in the presence of either IL-15 or GM-CSF and analyzed by the detection of the signal sequence generated by V␣14-J␣281 gene rearrangement. Surprisingly, in the presence of GM-CSF alone, but not IL-15, newly generated signal sequences were detected 24 hr after the onset of culture and maintained at least by the 36-hr time point (Fig. 3A Left) . No signal sequence was detected in the cultured cells from RAG-1 (Fig. 3A  Right) . Subsequently, we assessed the frequency of the generation of circular V␣14-J␣281 in this culture by using competitive PCR. As shown in Fig. 3B , the specificity of the signal sequences in the culture was confirmed by the competitive-PCR analysis; also, the frequency of the signal sequence was estimated to be one of several thousand input cells. This result It cannot be ruled out that the NKT precursor population still may be a mixture of heterogeneous cell populations and that only a part of them are true precursors of V␣14 NKT cells. If this is the case, the frequency of V␣14-J␣281 gene rearrangement would be higher than the above estimation.
To evaluate further the rearrangement events detected in the culture, we compared the frequency of V␣14 gene rearrangements in the culture with that in various lymphoid organs in situ. Consequently, genomic DNA was prepared from thymus, BM, spleen, and liver cells and subjected to competitive PCR. As shown in Fig. 3C , the frequency of the signal sequence in various tissues was estimated to be in the range of about 1͞10 5 in spleen to 1͞2,000 in liver. Because the frequency of the V␣14-J␣281-mediated signal sequences was around one in several thousand starting cells in the culture (Fig. 3B) , it is in the range equivalent to that in normal liver tissue. The frequency of the coding sequence in each organ also was examined by competitive PCR. The ratio of the signal sequence to the coding sequence resulting from V␣14-J␣281 gene rearrangement was the highest in the liver (1.7%) and BM (1.7%) (Fig. 3C Right) , suggesting preferential, ongoing gene recombination in these tissues. Subsequently, we confirmed the expression of GM-CSF receptor in the pre-NKT cell population (Fig. 4A) (Fig. 4A ). These observations also ensured that sCD3 Ϫ pre-NKT cells possessed a precursor potential to differentiate into mature NKT cells by GM-CSFR-mediated V␣14 gene rearrangement.
Finally, we addressed the role of GM-CSFR by using ␤c-deficient mice, in which GM-CSFR-mediated signaling pathway was abrogated because of lack of a signaling-receptor subunit, ␤c chain (19) . In ␤c-deficient mice, both percentages and absolute numbers of NKT cells in all lymphoid tissues examined were reduced significantly compared with wild-type controls (Fig. 4 B and C) , whereas the numbers of other cell types, including T, B, and NK cells, were similar (data not shown). Furthermore, the ␤c-deficient mice showed 2-to 10-fold decreased numbers of cells with rearranged V␣14-J␣281 TCR␣ as assessed by competitive PCR (Fig. 4D) . These results indicated strongly that GM-CSF was crucial for the development of V␣14 NKT cells in vivo.
DISCUSSION
In this report, we have identified a unique pre-NKT cell population (V␤8. (16) . These results suggest that pre-TCR-dependent selection (␤-selection) and subsequent proliferation are required for NKT cell development. Although the physiological significance remains to be clarified, NKT cells appear to express an alternative-spliced form of pT␣, ''pT b ␣,'' which is different from that of pre-T cells and has been identified recently in ''␤-only cells'' in the periphery of TCR C␣-deficient mice (22) . In addition to the characteristic phenotype of pre-NKT cells, GM-CSFR is expressed in sCD3 Ϫ pre-NKT cells at a level comparable to myeloid cells in BM (Fig. 4A) , although GM-CSFR is known to be expressed on myeloid cells but not on conventional T cells (23) . Moreover, newly generated signal sequence and rearranged V␣14-J␣281 genomic DNA are detectable after culture with GM-CSF alone without feeder cells, indicating the de novo generation of mature phenotype of V␣14 NKT cells. Therefore, it is likely that GM-CSF directly acts on sCD3 Ϫ pre-NKT cells and may induce TCR␣ gene rearrangement (Fig. 3A) (although the possibility cannot be completely excluded that minor contaminants in sorted samples, but not sCD3 Ϫ NKT cells, are direct targets of GM-CSF, and that V␣14 NKT cell development is facilitated by such GM-CSFresponsive contaminants).
One intriguing explanation of the effect of GM-CSF is that GM-CSF allows the recombination machinery accessible to TCR␣ gene loci. In some pre-B cell lines, certain humoral factors, such as bacterial lipopolysaccharide and interferon ␥, are demonstrated to induce germ-line transcription and rearrangement of Ig locus by converting the inactive Ig locus to an accessible recombinase substrate (24, 25) . Similarly, germline transcripts of J␥-C␥ appear to be induced by IL-3, implying that IL-3 allowed the TCR␥ loci to open (26) . Furthermore, other cytokines, such as IL-4, erythropoietin, and GM-CSF, are reported to induce transcription from germ-line TCR␥ loci (26) . Based on the above findings, GM-CSF might make TCR␣ gene loci accessible for preexisting recombination enzymes The ␤c-deficient mice show significantly reduced numbers of V␣14 NKT cells (Fig. 4 B and C) . These results are in good agreement with in vitro findings that GM-CSF is crucial for V␣14 NKT cell development and TCR␣ gene rearrangements (Figs. 2 and 3 A and B) . This is also confirmed by the molecular analysis that the frequency of V␣14-J␣281 gene rearrangement is reduced significantly. It is interesting, however, that the gene rearrangements are not blocked completely (Fig. 4D) , suggesting that the V␣14-J␣281 rearrangements are compensated to some extent by other redundant factors. There exists a functional redundancy between GM-CSF and IL-3 (27) . Thus, V␣14 NKT cells in ␤c-mutant mice might be generated by IL-3. In fact, IL-3-mediated signaling can be transduced through an additional IL-3␤-subunit, ␤IL-3, in ␤c-mutant mice (28) . In any event, our results suggest that ␤c-mediated signals are critical for V␣14 NKT cell development in vivo.
Finally, we propose a model of the differentiation scenario of V␣14NKT cells from the sCD3 Ϫ pre-NKT cells as follows.
(i) The first step before V␣14 gene rearrangement is the step at which the precursors can be maintained or expanded to some extent solely by IL-15, but not GM-CSF (unpublished data). (ii) The V␣14 gene rearrangement step is the step at which GM-CSF alone, but not IL-15, could facilitate V␣14 gene rearrangement. This observation also is supported by the fact that decreased but significant numbers of NKT cells develop in IL-15 receptor ␣-deficient mice (29) . In this step, stroma cells are dispensable, as shown in Fig. 3A. ( iii) The positive selection step is the step at which NKT cells, after successful NKT cell receptor (V␣14J␣281 TCR␣) formation, are positively selected by CD1͞␤ 2 m molecules on stromal cells, similar to positive selection of conventional T cells in the thymus.
